<DOC>
	<DOCNO>NCT00160667</DOCNO>
	<brief_summary>Study ass efficacy , safety tolerability brivaracetam post-herpetic neuralgia ( PHN ) . Duration 7 week divide 3 period up-titration , down-titration .</brief_summary>
	<brief_title>A Study Assessing Efficacy Brivaracetam Subjects With Persistent Pain After Shingles ( Post-herpetic Neuralgia )</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Male/female subject age 18 year old . Pain present least 6 month heal acute herpes zoster skin rash . Pain intensity score assess 11point numerical pain rating scale score least 4 screen visit average weekly score least 4 11point numerical pain rating scale baseline period . Subject get kind psychological support help cope pain biofeedback behavioral cognitive therapy . Subject undergone schedule neurolytic neurosurgical therapy postherpetic neuralgia ( PHN ) receive transelectrical neural stimulation ( TENS . Tricyclic antidepressant ( TCAs ) nonsteroidal antiinflammatory drug ( NSAIDs ) permit opioid analgesic ( `` strong '' opioids forbid ) start less 30 day and/or stabilize prior screening and/or expect keep stable study . Intake two pain treatment trial entry ( screen visit ) include Tricyclic antidepressant ( TCAs ) , nonsteroidal antiinflammatory drug ( NSAIDs ) permit opioid analgesic . Subject treat Carbamazepine indication . Known coexistent source painful peripheral neuropathy systemic disease associate secondary painful neuropathy . Subject treat four week prior screen visit `` strong '' opioid analgesic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Post-herpetic Neuralgia ( PHN )</keyword>
	<keyword>Brivaracetam</keyword>
</DOC>